|
Actemra (tocilizumab)
|
|
Important safety update of prescribing information for xeloda® (capecitabine)
|
|
Information on Actemra
|
|
Eligard (leuprorelin acetate) - Medication errors associated with leakage due to overtightening of the safety needle
|
|
CELLCEPT (mycophenolate mofetil): risk of teratogenicity guide
|
|
Safety notice on medical device «Prismaflex»
|
|
Herceptin (trastuzumab). Importance of cardiac monitoring to reduce the frequency and severity of left ventricular dysfunction and congestive heart failure during trastuzumab therapy
|
|
Mirabegron (Betmiga) - new recommendations about the risk of increase in blood pressure
|
|
Important safety update of prescribing information for Xeloda® (capecitabine)
|
|
Bioparox (fusafungine) aerosol will no longer be available on the market
|
